XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.3

ACCRUED LIABILITIES (Tables)

9 Months Ended

Sep. 30, 2025

Payables and Accruals [Abstract]

Schedule of Accrued Liabilities

Accrued liabilities consisted of the following as of September 30, 2025 and December 31, 2024:

(In thousands)						SEPTEMBER 30, 2025						DECEMBER 31, 2024
CRO and clinical trial costs						$	6,263					$	18,968
Manufacturing activities						26,169						11,839
Professional legal and accounting fees						963						475
Interest payable						—						2,186
Gross-to-net adjustments						4,105						1,166
Other						2,428						915
Total Accrued Liabilities						$	39,928					$	35,549

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the components of accrued liabilities.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration